Omalizumabin Tedaviye Dirençli Atopik Dermatit ve Kontakt Dermatit Tedavisindeki Etkinliği
Omalizumab selektif olarak immünoglobulin E antikorlarına bağlanır ve alerjik astım tedavisi için onaylanmıştır. Bununla birlikte dermatolojik hastalıklarda kullanımı giderek artmaktadır. Bu makalede, omalizumab ile başarılı bir şekilde ve yan etki görülmeden tedavi edilmiş biri atopik dermatitli, diğer ikisi kontakt dermatitli olmak üzere tedaviye direnç gösteren üç olgu sunduk.
Efficacy of Omalizumab in Treatment of Therapy-Resistant Atopic Dermatitis and Contact Dermatitis
Omalizumab selectively binds to immunoglobulin E antibodies and is approved for treatment of allergic asthma. However, its use in dermatologic diseases is increasing. Here, we report three treatment resistant cases, one with atopic dermatitis the other two with contact dermatitis successfully treated with omalizumab with no side effect.
___
- El-Qutob D. Off-label uses of omalizumab. Clin Rev Allergy Immunol
2016;50:84-96.
- Chia JC, Mydlarski PR. Dermatologic uses of omalizumab. J Dermatolog
Treat 2017;28:332-337.
- Peng W, Novak N. Pathogenesis of atopic dermatitis. Clin Exp Allergy
2015;45:566-574.
- Novak N. An update on the role of human dendritic cells in patients with
atopic dermatitis. J Allergy Clin Immunol 2012;129:879-886.
- Tang TS, Bieber T, Williams HC. Are the concepts of induction of remission
and treatment of subclinical inflammation in atopic dermatitis clinically
useful? J Allergy Clin Immunol 2014;133:1615-1625.
- Kim DH, Park KY, Kim BJ, et al. Anti-immunoglobulin E in the treatment of
refractory atopic dermatitis. Clin Exp Dermatol 2013;38:496-500.
- Park SY, Choi MR, Na JI, et al. Recalcitrant atopic dermatitis treated with
omalizumab. Ann Dermatol 2010;22:349-352.
- Wang HH, Li YC, Huang YC. Efficacy of omalizumab in patients with atopic
dermatitis: A systematic review and meta-analysis. J Allergy Clin Immunol
2016;138:1719-1722.
- Zink A, Gensbaur A, Zirbs M, et al. Targeting IgE in severe atopic dermatitis
with a combination of immunoadsorption and omalizumab. Acta Derm
Venereol 2016;96:72-76.
- Mowad CM, Anderson B, Scheinman P, et al. Allergic contact dermatitis:
Patient management and education. J Am Acad Dermatol 2016;74:1043-
1054.
- Kostner L, Anzengruber F, Guillod C, et al. Allergic contact dermatitis.
Immunol Allergy Clin North Am 2017;37:141-152.
- Mur Gimeno P, Martín Iglesias A, Lombardero Vega M, et al. Occupational
wheat contact dermatitis and treatment with omalizumab. J Investig
Allergol Clin Immunol 2013;23:287-288.
- Massanari M, Holgate ST, Busse WW, et al. Effect of omalizumab on
peripheral blood eosinophilia in allergic asthma. Respir Med 2010;104:188-
196.
- Holgate S, Casale T, Wenzel S, et al. The anti-inflammatory effects of
omalizumab confirm the central role of IgE in allergic inflammation. J
Allergy Clin Immunol 2005;115:459-465.
- Prussin C, Griffith DT, Boesel KM, et al. Omalizumab treatment
downregulates dendritic cell FcepsilonRI expression. J Allergy Clin Immunol
2003;112:1147-1154.